Phreesia (NYSE:PHR) Given Buy Rating at DA Davidson

DA Davidson reissued their buy rating on shares of Phreesia (NYSE:PHR) in a report released on Thursday, MarketBeat reports. DA Davidson currently has a $32.00 price target on the stock.

Several other equities analysts have also commented on PHR. Truist Financial reaffirmed a buy rating and set a $29.00 target price on shares of Phreesia in a report on Monday, July 1st. JMP Securities reaffirmed a market outperform rating and set a $30.00 price objective on shares of Phreesia in a research note on Friday, August 30th. Canaccord Genuity Group lowered their target price on Phreesia from $37.00 to $34.00 and set a buy rating for the company in a research note on Friday, May 31st. Needham & Company LLC restated a buy rating and set a $29.00 price target on shares of Phreesia in a research report on Thursday. Finally, KeyCorp lowered their price objective on Phreesia from $27.00 to $25.00 and set an overweight rating for the company in a research report on Thursday, July 11th. One investment analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company. According to MarketBeat, Phreesia currently has an average rating of Moderate Buy and a consensus price target of $30.42.

Phreesia Stock Down 8.3 %

Shares of NYSE PHR opened at $23.55 on Thursday. The stock has a market capitalization of $1.35 billion, a P/E ratio of -10.85 and a beta of 0.93. Phreesia has a one year low of $12.05 and a one year high of $29.16. The firm’s 50 day simple moving average is $23.38 and its two-hundred day simple moving average is $22.77. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.76 and a quick ratio of 1.76.

Insider Activity

In related news, General Counsel Allison C. Hoffman sold 14,110 shares of the firm’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $26.03, for a total value of $367,283.30. Following the completion of the sale, the general counsel now owns 121,003 shares of the company’s stock, valued at $3,149,708.09. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Phreesia news, CEO Chaim Indig sold 2,644 shares of the company’s stock in a transaction that occurred on Tuesday, July 16th. The stock was sold at an average price of $23.74, for a total transaction of $62,768.56. Following the transaction, the chief executive officer now owns 1,219,361 shares in the company, valued at approximately $28,947,630.14. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, General Counsel Allison C. Hoffman sold 14,110 shares of the stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $26.03, for a total value of $367,283.30. Following the completion of the transaction, the general counsel now directly owns 121,003 shares of the company’s stock, valued at approximately $3,149,708.09. The disclosure for this sale can be found here. Over the last three months, insiders have sold 29,337 shares of company stock valued at $736,750. Company insiders own 5.80% of the company’s stock.

Institutional Investors Weigh In On Phreesia

Several hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. lifted its position in Phreesia by 4.4% during the fourth quarter. Vanguard Group Inc. now owns 4,628,441 shares of the company’s stock valued at $107,148,000 after buying an additional 194,035 shares during the period. Champlain Investment Partners LLC bought a new position in shares of Phreesia in the 1st quarter worth about $29,941,000. Brown Advisory Inc. lifted its position in Phreesia by 22.2% during the 4th quarter. Brown Advisory Inc. now owns 3,950,356 shares of the company’s stock valued at $91,451,000 after acquiring an additional 716,374 shares during the period. Boston Partners bought a new stake in Phreesia during the first quarter worth about $669,000. Finally, Blair William & Co. IL grew its holdings in Phreesia by 42.6% in the first quarter. Blair William & Co. IL now owns 752,700 shares of the company’s stock worth $18,012,000 after purchasing an additional 224,950 shares during the period. 92.10% of the stock is currently owned by institutional investors.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.